← Evidence map

ArticleOncogene2021

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.

Che-Pei Kung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

66 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33110236